“Without a Doubt Hydroxychloroquine Protocols Helped Me – I Was Symptom Free in 4 Days” – Congressman Louie Gohmert Speaks Out on His Bout with COVID-19

Source: The Gateway Pundit. Author: Jim Hoft

Texas Republican Louie Gohmert announced in July he had tested positive for the China conservative.

Rep. Gohmert later announced he will be taking hydroxychloroquine to battle COVID-19 after being diagnosed with the virus.

The Texas Republican, 66, said he and his doctor agreed that he should begin taking the anti-malarial drug, which some doctors believe can reduce the effects of the coronavirus.

“My doctor and I are all in,” Gohmert said in an interview with Fox News’ Sean Hannity. “I got a text before I came on from a friend doctor who just found out he had it, and he started the regimen, too — zinc and hydroxychloroquine. And that will start in a day or two, so thank you.”

Gohmert said while he was diagnosed with the virus, he is asymptomatic.

On Wednesday Congressman Louie Gohmert updated The Gateway Pundit on his condition:

“Without a doubt, the hydroxychloroquine (HCQ) protocols helped me. I was prescribed hydroxychloroquine, azithromycin and a steroid nebulizer. I also took zinc and some vitamins. I was still pretty weak but was completely symptom free in four days. It is a shame some people are politicizing the use of HCQ protocols and citing some debunked studies to claim HCQ is unsafe and should not be utilized as a treatment for coronavirus.”

Congressman Louie Gohmert







Related: GOP Rep. Louie Gohmert Says He’s Taking Hydroxychloroquine to Treat Coronavirus

Rep. Louie Gohmert’s update on health following COVID-19 and his hydroxychloroquine treatment

US Congressman Andy Biggs interviews Dr James Todaro on COVID-19, hydroxy and reopening schools

NYC Councilman Paul Vallone credits Hydroxychloroquine for saving his life from COVID-19

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »